$1.18
-0.02[-1.67%]
At close: Apr 29
$1.18
0[0.00%]
After Hours: 6:03PM EDT
Aclaris Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Aclaris Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/14/2024 | AM | ACRS | Q1 | -$0.42 | -$0.29 | — | — | $2.53M | $1.37M | — | — | Get Alert |
02/27/2024 | AM | ACRS | Q4 | -$0.41 | -$0.34 | -$0.30 | 11.76% | $7.75M | $3.36M | $17.57M | 422.92% | Get Alert |
11/06/2023 | AM | ACRS | Q3 | -$0.30 | -$0.48 | -$0.41 | 14.58% | $19.02M | $1.57M | $9.28M | 491.21% | Get Alert |
08/07/2023 | AM | ACRS | Q2 | -$0.31 | -$0.45 | -$0.42 | 6.67% | $1.53M | $1.90M | $1.87M | -1.63% | Get Alert |
05/08/2023 | AM | ACRS | Q1 | -$0.31 | -$0.44 | -$0.42 | 4.55% | $1.45M | $1.75M | $2.53M | 44.46% | Get Alert |
02/23/2023 | AM | ACRS | Q4 | -$0.37 | -$0.45 | -$0.41 | 8.89% | $1.50M | $1.99M | $7.75M | 289.60% | Get Alert |
11/08/2022 | AM | ACRS | Q3 | -$0.35 | -$0.40 | -$0.30 | 25.00% | $1.66M | $1.60M | $19.02M | 1088.62% | Get Alert |
08/03/2022 | AM | ACRS | Q2 | -$0.34 | -$0.36 | -$0.31 | 13.89% | $1.82M | $1.61M | $1.53M | -5.09% | Get Alert |
05/10/2022 | AM | ACRS | Q1 | -$0.57 | -$0.40 | -$0.31 | 22.50% | $1.78M | $1.66M | $1.45M | -12.47% | Get Alert |
02/24/2022 | AM | ACRS | Q4 | -$0.30 | -$0.36 | -$0.37 | -2.78% | $1.58M | $1.79M | $1.50M | -16.15% | Get Alert |
11/02/2021 | AM | ACRS | Q3 | -$0.25 | -$0.28 | -$0.35 | -25.00% | $1.45M | $1.77M | $1.66M | -6.27% | Get Alert |
08/05/2021 | AM | ACRS | Q2 | -$0.28 | -$0.29 | -$0.34 | -17.24% | $2.05M | $1.69M | $1.82M | 7.93% | Get Alert |
05/07/2021 | AM | ACRS | Q1 | -$0.37 | -$0.29 | -$0.57 | -96.55% | $1.41M | $1.69M | $1.78M | 5.15% | Get Alert |
02/25/2021 | AM | ACRS | Q4 | -$0.45 | — | -$0.30 | — | $1.09M | — | $1.58M | — | Get Alert |
11/04/2020 | AM | ACRS | Q3 | -$0.56 | — | -$0.25 | — | $983.00K | — | $1.45M | — | Get Alert |
08/07/2020 | AM | ACRS | Q2 | -$0.76 | — | -$0.28 | — | $5.87M | — | $2.05M | — | Get Alert |
05/07/2020 | PM | ACRS | Q1 | -$0.91 | — | -$0.37 | — | $1.26M | — | $1.41M | — | Get Alert |
02/25/2020 | PM | ACRS | Q4 | -$0.99 | -$1.24 | -$0.45 | 63.71% | $3.67M | $3.47M | $1.09M | -68.44% | Get Alert |
11/07/2019 | PM | ACRS | Q3 | -$1.06 | -$0.57 | -$0.56 | 1.75% | $1.63M | $5.82M | $983.00K | -83.11% | Get Alert |
Aclaris Therapeutics (ACRS) is scheduled to report earnings on May 14, 2024. The last reported earnings were for reported on February 27, 2024 for Q4.
The Actual EPS was $-0.30, which beat the estimate of $-0.34.
The Actual Revenue was $17.6M, which beat the estimate of $3.4M.
Browse earnings estimates, EPS, and revenue on all stocks.